David Burger (Oct. 20, 1964) received his Pharmacy Degree at the Utrecht University in 1990. He completed his PhD thesis, titled “Bio-analysis and clinical pharmacokinetics of antiretroviral agents in HIV-infected individuals” at the Slotervaart Hospital, Amsterdam, in 1994. After this, he moved to the Radboud University Medical Centre, Nijmegen, for his hospital pharmacist training.
Since 1997 he has been leading a research group focussing on clinical pharmacology of antimicrobial agents with emphasis on HIV, TB, fungal infections, and HCV. He is a member of the Editorial Board of the www.hiv-druginteractions.org and www.hep-druginteractions.org websites on behalf of the European AIDS Clinical Society.
More recently, a research line on clinical pharmacology of cancer treatment was initiated within the Department of Pharmacy; as a result David is now on the Editorial Board of http://www.cancer-druginteractions.org.
He is a Section Editor of the Dutch Journal of Medicine (NTvG) and the British Journal of Clinical Pharmacology. He is a member of the editorial boards of TDM, JAIDS, JAC, Antiviral Therapy.
Since April 2011 he has been appointed as a Professor of Clinical Pharmacy at the Radboud University Nijmegen. He is (co-) author of more than 400 publications in this field and has supervised 25 completed PhD theses. The topics of his interest are drug-drug interactions, pediatric pharmacology, therapeutic drug monitoring, and operational research in resource-limited countries.